Dihydroquinazolinone compound or pharmacologically acceptable salt, and cell growth inhibitor
US-11566017-B2 · Jan 31, 2023 · US
Kazami Junichi is listed as an inventor on 10 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Kazami Junichi |
| Total patents | 10 |
| First publication | Jul 6, 2017 |
| Latest publication | Jan 31, 2023 |
Publications ranked by popularity score, then publication date.
US-11566017-B2 · Jan 31, 2023 · US
US-10975091-B2 · Apr 13, 2021 · US
US-2021061789-A1 · Mar 4, 2021 · US
US-2020055868-A1 · Feb 20, 2020 · US
US-10421762-B2 · Sep 24, 2019 · US
US-2018327418-A1 · Nov 15, 2018 · US
US-10059720-B2 · Aug 28, 2018 · US
US-10005762-B2 · Jun 26, 2018 · US
US-2017362209-A1 · Dec 21, 2017 · US
US-2017190715-A1 · Jul 6, 2017 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Astellas Pharma Inc | 8 |
| Kotobuki Pharmaceutical Co Ltd | 8 |
| Riken | 2 |
| Japanese Found For Cancer Res | 2 |
| Yakult Honsha Kk | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P43/00 | 8 |
| A61P7/12 | 8 |
| A61K31/5377 | 8 |
| A61K31/4433 | 8 |
| A61K31/444 | 8 |